• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃兹蛋白通过Hippo信号通路促进食管鳞状细胞癌进展。

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway.

作者信息

Ma Lijuan, Liu Li, Ji Min, Su Liping, Guan Yaling, Xiao Jinling, Pu Hongwei

机构信息

State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Physiology, School of Basic Medical Sciences, Xinjiang Medical University, No. 567, Shangde North Road, Urumqi 830017, Xinjiang, China.

Department of Pathology, First Affiliated Hospital, Xinjiang Medical University, No. 137, Liyushan South Road, Urumqi 830054, Xinjiang, China.

出版信息

Open Life Sci. 2023 Sep 30;18(1):20220743. doi: 10.1515/biol-2022-0743. eCollection 2023.

DOI:10.1515/biol-2022-0743
PMID:37791063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10543706/
Abstract

The aim of this study was to analyze the role of Ezrin in esophageal squamous cell carcinoma (ESCC) and investigate potential therapeutic targets for ESCC by interfering with Ezrin expression. Bioinformatics analysis revealed that Ezrin expression differed significantly among patients with different clinical stage ESCC. Moreover, there was a significant correlation between Ezrin and yes-associated protein/connective tissue growth factor (YAP/CTGF) levels in esophageal cancer. Sixty paraffin-embedded ESCC tissue samples were examined and Ezrin and YAP/CTGF levels were determined using immunohistochemistry. The positive expression rates of Ezrin and YAP/CTGF were significantly lower in adjacent tissues than in ESCC tissues. Furthermore, knockdown of Ezrin expression inhibited colony formation and reduced cell migration and invasion. Compared with control ESCC cells, protein expression levels of YAP and CTGF were significantly downregulated in cells with Ezrin knocked down. We conclude that Ezrin may be involved in ESCC progression through the Hippo signaling pathway.

摘要

本研究旨在分析埃兹蛋白(Ezrin)在食管鳞状细胞癌(ESCC)中的作用,并通过干扰Ezrin表达来探索ESCC潜在的治疗靶点。生物信息学分析显示,不同临床分期的ESCC患者中Ezrin表达存在显著差异。此外,食管癌中Ezrin与Yes相关蛋白/结缔组织生长因子(YAP/CTGF)水平之间存在显著相关性。检测了60例石蜡包埋的ESCC组织样本,并采用免疫组织化学法测定Ezrin和YAP/CTGF水平。Ezrin和YAP/CTGF在癌旁组织中的阳性表达率显著低于ESCC组织。此外,Ezrin表达的敲低抑制了集落形成,并减少了细胞迁移和侵袭。与对照ESCC细胞相比,Ezrin敲低的细胞中YAP和CTGF的蛋白表达水平显著下调。我们得出结论,Ezrin可能通过Hippo信号通路参与ESCC的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/5edd2e6aa9b6/j_biol-2022-0743-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/214a629d2073/j_biol-2022-0743-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/578d62c70cc9/j_biol-2022-0743-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/39021a5a451b/j_biol-2022-0743-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/08b6b1556bc8/j_biol-2022-0743-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/536bc0dda3c8/j_biol-2022-0743-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/5edd2e6aa9b6/j_biol-2022-0743-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/214a629d2073/j_biol-2022-0743-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/578d62c70cc9/j_biol-2022-0743-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/39021a5a451b/j_biol-2022-0743-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/08b6b1556bc8/j_biol-2022-0743-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/536bc0dda3c8/j_biol-2022-0743-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4353/10543706/5edd2e6aa9b6/j_biol-2022-0743-fig006.jpg

相似文献

1
Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway.埃兹蛋白通过Hippo信号通路促进食管鳞状细胞癌进展。
Open Life Sci. 2023 Sep 30;18(1):20220743. doi: 10.1515/biol-2022-0743. eCollection 2023.
2
OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma.OTUB2通过调控YAP1/TAZ促进食管鳞状细胞癌进展。
Biol Proced Online. 2022 Jul 18;24(1):10. doi: 10.1186/s12575-022-00169-9.
3
Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells.埃兹蛋白在食管鳞状癌细胞生长和侵袭中的作用。
Int J Cancer. 2009 Jun 1;124(11):2549-58. doi: 10.1002/ijc.24216.
4
Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.Gli1 与 YAP1 相互作用促进食管鳞癌的发生。
J Cell Physiol. 2020 Nov;235(11):8224-8235. doi: 10.1002/jcp.29477. Epub 2020 Jan 20.
5
L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.L1CAM 通过刺激 ezrin 转录促进食管鳞癌的致癌性。
J Mol Med (Berl). 2017 Dec;95(12):1355-1368. doi: 10.1007/s00109-017-1595-4. Epub 2017 Sep 22.
6
Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.E3 泛素连接酶 PARK2 调控 Hippo/YAP 信号通路及食管鳞癌的进展
Theranostics. 2020 Jul 25;10(21):9443-9457. doi: 10.7150/thno.46078. eCollection 2020.
7
MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.微小RNA-145通过靶向食管鳞状细胞癌中的结缔组织生长因子(CTGF)抑制细胞迁移和侵袭并调节上皮-间质转化(EMT)
Med Sci Monit. 2016 Oct 23;22:3925-3934. doi: 10.12659/msm.897663.
8
DRP-1, ezrin and E-cadherin expression and the association with esophageal squamous cell carcinoma.动力相关蛋白1(DRP-1)、埃兹蛋白和E-钙黏蛋白的表达及其与食管鳞状细胞癌的关系。
Oncol Lett. 2014 Jul;8(1):133-138. doi: 10.3892/ol.2014.2114. Epub 2014 May 7.
9
NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143.NEK2 通过磷酸化 YAP1 的 Thr-143 促进 ESCC 的迁移和增殖。
Cell Commun Signal. 2022 Jun 15;20(1):87. doi: 10.1186/s12964-022-00898-0.
10
Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.下调 miR-31 通过 hippo 通路刺激 LATS2 的表达,并促进食管鳞癌细胞的上皮间质转化。
J Exp Clin Cancer Res. 2017 Nov 16;36(1):161. doi: 10.1186/s13046-017-0622-1.

引用本文的文献

1
YAP as a therapeutic target in esophageal squamous cell carcinoma: insights and strategies.YAP作为食管鳞状细胞癌的治疗靶点:见解与策略
Ann Med. 2025 Dec;57(1):2536200. doi: 10.1080/07853890.2025.2536200. Epub 2025 Jul 22.

本文引用的文献

1
YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches.YAP/TAZ 作为癌症的主要调控因子:调节、功能和治疗方法。
Nat Cancer. 2023 Jan;4(1):9-26. doi: 10.1038/s43018-022-00473-z. Epub 2022 Dec 23.
2
Neoadjuvant Therapy in Esophageal Cancer.食管癌的新辅助治疗。
Thorac Surg Clin. 2022 Nov;32(4):447-456. doi: 10.1016/j.thorsurg.2022.06.003.
3
Expression Patterns of Ezrin and AJAP1 and Clinical Significance in Breast Cancer.埃兹蛋白和AJAP1在乳腺癌中的表达模式及其临床意义
Front Oncol. 2022 Mar 4;12:831507. doi: 10.3389/fonc.2022.831507. eCollection 2022.
4
SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway.固醇调节元件结合蛋白1(SREBP1)通过Hippo-YAP信号通路上调富含半胱氨酸的血管生成素61(CYR61)/结缔组织生长因子(CTGF),从而促进侵袭性表型。
Endocr Relat Cancer. 2021 Dec 13;29(2):47-58. doi: 10.1530/ERC-21-0256.
5
Glycogen accumulation and phase separation drives liver tumor initiation.糖原积累和相分离驱动肝肿瘤发生。
Cell. 2021 Oct 28;184(22):5559-5576.e19. doi: 10.1016/j.cell.2021.10.001. Epub 2021 Oct 21.
6
Synthetic molecules targeting yes associated protein activity as chemotherapeutics against cancer.针对 YAP 活性的合成分子作为癌症化疗药物。
Chem Biol Drug Des. 2021 Dec;98(6):1025-1037. doi: 10.1111/cbdd.13960. Epub 2021 Oct 3.
7
Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling.埃兹蛋白通过 YAP 和 Akt 信号通路调节类风湿关节炎滑膜血管生成。
J Cell Mol Med. 2021 Oct;25(19):9378-9389. doi: 10.1111/jcmm.16877. Epub 2021 Aug 29.
8
Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using F-FDF PET/CT, and .利用F-FDG PET/CT预测骨肉瘤患儿转移和化疗反应的初步放射基因组学证据 以及 。 你提供的原文最后有个“and.”,感觉不太完整准确,若有更完善的内容欢迎继续向我提问。
Cancers (Basel). 2021 May 28;13(11):2671. doi: 10.3390/cancers13112671.
9
CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer.CTGF 通过激活三阴性乳腺癌中的 FAK 信号来调节细胞增殖、迁移和葡萄糖代谢。
Oncogene. 2021 Apr;40(15):2667-2681. doi: 10.1038/s41388-021-01731-7. Epub 2021 Mar 10.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.